{"DataElement":{"publicId":"2664664","version":"1","preferredName":"Immunohistochemistry Positive Staining Baseline Result Code","preferredDefinition":"The code that represents the percentage of positively staining cells at the beginning of the period of evaluation.","longName":"IHC_P_S_BSL_RLST_CD","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2664654","version":"1","preferredName":"Immunohistochemistry Staining Method Finding Baseline Result","preferredDefinition":"Information pertaining to the immunohistochemical staining results at the beginning of the period of evaluation.","longName":"IHC_SMF_BSL_RSLT","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2528743","version":"1","preferredName":"Immunohistochemistry Staining Method Finding","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).","longName":"C23020:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2041585F-41BE-0280-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2664652","version":"1","preferredName":"Baseline Result","preferredDefinition":"Baseline; an imaginary standard by which things are measured or compared.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C25213:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B1A4D-61A5-58C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-07-17","modifiedBy":"ONEDATA","dateModified":"2007-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B1A4D-61B6-58C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-07-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2664659","version":"1","preferredName":"Immunohistochemistry Positive Staining Result Code","preferredDefinition":"The code that represents the percentage of positively staining cells.","longName":"IHC_POS_STN_RSLT_CD","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"II","valueDescription":">50% positively staining cells","ValueMeaning":{"publicId":"2664660","version":"1","preferredName":">50% positively staining cells","longName":"2664660","preferredDefinition":"Greater than 50 percent positively staining cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B4ACE-4370-6040-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"357B4ACE-438A-6040-E044-0003BA3F9857","beginDate":"2007-07-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-07-17","modifiedBy":"SHIDED","dateModified":"2007-07-17","deletedIndicator":"No"},{"value":"I","valueDescription":"5 - 50% positively staining cells","ValueMeaning":{"publicId":"2664661","version":"1","preferredName":"5 - 50% positively staining cells","longName":"2664661","preferredDefinition":"5  to 50 percent positively staining cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B4ACE-4396-6040-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"357B4ACE-43B0-6040-E044-0003BA3F9857","beginDate":"2007-07-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-07-17","modifiedBy":"SHIDED","dateModified":"2007-07-17","deletedIndicator":"No"},{"value":"0","valueDescription":"< 5% positively staining cells","ValueMeaning":{"publicId":"2664662","version":"1","preferredName":"< 5% positively staining cells","longName":"2664662","preferredDefinition":"Less than 5 percent positively staining cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B4ACE-43BC-6040-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"357B4ACE-43D6-6040-E044-0003BA3F9857","beginDate":"2007-07-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-07-17","modifiedBy":"SHIDED","dateModified":"2007-07-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2664658","version":"1","preferredName":"Immunohistochemistry Positive Staining Result Code","preferredDefinition":"Histochemical localization of immunoreactive substances using labeled antibodies as reagents. (MSH98):Involving advantage or good.:Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:A system of numbered categories for representation of data.","longName":"C16722:C25246:C50753:C20200:C2","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry","conceptCode":"C16722","definition":"Histochemical localization of immunoreactive substances using labeled antibodies as reagents. (MSH98)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Staining","conceptCode":"C50753","definition":"Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B4A4A-7AE1-611A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-07-17","modifiedBy":"ONEDATA","dateModified":"2007-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357B4A4A-7AF2-611A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-07-17","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Baseline Result","type":"Preferred Question Text","description":"Baseline Result","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"357B4A4A-7B09-611A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-07-17","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}